Predict your next investment

Angel Investor (Individual)
bermanmedical.com

See what CB Insights has to offer

Investments

6

Portfolio Exits

3

About Michael Berman

Michael Berman is a medical device investor/entrepreneur who serves on the boards of 9 emerging medical device companies. Mr. Berman was a co-founder of Velocimed which was sold to St. Jude Medical in April, 2005. From 1995-2000 Mr. Berman was the President of the Cardiology business of Boston Scientific. About Michael's education, He's completed a BS from Cornell University in 1979and MBA from Cornell University in 1986.

Michael Berman Headquarter Location

10727 Genevieve Lane

Minnetonka, Minnesota, 55305,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Michael Berman News

Michael Edelman Named President of M&T Realty Capital Corporation

Jan 7, 2022

In an expansion of its current leadership team, M&T Realty Capital Corporation (M&T RCC) today announced that Michael Edelman, previously Group Vice President, has been named President of the organization. In this new role, Edelman will report directly to M&T RCC CEO, Michael Berman, and will be responsible for external customer and capital relationships, including continuing his previous work leading the organization’s relationships with Fannie Mae and Freddie Mac. Edelman, a 6-year veteran of M&T RCC, will also focus on growing the FHA and the Life Co-Placement platforms as well as enhancing M&T RCC’s integration with M&T Bank. “Mike has been a key player in the lending arena for over 25 years, and we welcome his increased leadership role at M&T RCC,” said Berman. “I look forward to collaborating with Mike and our Chief Operating Officer, Christine Chandler, as the three of us and our team continue to grow our lending and servicing enterprise with the highest standards of excellence.” Prior to joining M&T, Edelman held various roles at Freddie Mac in NYC, and ultimately served as Vice President managing Freddie Mac’s Northeast Region. In that role, he was responsible for lender development, managing a staff of over 25 professionals, overseeing a loan portfolio over $30 billion and annual origination volume of approximately $5 billion, including mixed-use properties, senior housing, co-ops, LIHTC and bond credit enhancements. [To share your insights with us, please write to  sghosh@martechseries.com ]

Michael Berman Investments

6 Investments

Michael Berman has made 6 investments. Their latest investment was in Rebiotix as part of their Series B on August 8, 2014.

CBI Logo

Michael Berman Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

8/4/2014

Series B

Rebiotix

$25M

No

2

2/9/2012

Series A

Subscribe to see more

$99M

Subscribe to see more

10

11/4/2011

Series A

Subscribe to see more

$99M

Subscribe to see more

0

3/11/2011

Series C - II

Subscribe to see more

$99M

Subscribe to see more

10

8/19/2009

Series C

Subscribe to see more

$99M

Subscribe to see more

0

Date

8/4/2014

2/9/2012

11/4/2011

3/11/2011

8/19/2009

Round

Series B

Series A

Series A

Series C - II

Series C

Company

Rebiotix

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$25M

$99M

$99M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

10

0

10

0

Michael Berman Portfolio Exits

3 Portfolio Exits

Michael Berman has 3 portfolio exits. Their latest portfolio exit was Rebiotix on April 05, 2018.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/5/2018

Acquired

3

6/14/2017

Acquired

Subscribe to see more

Subscribe to see more

10

9/19/2012

Acquired

Subscribe to see more

Subscribe to see more

0

Date

4/5/2018

6/14/2017

9/19/2012

Exit

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

Acquirer

Subscribe to see more

Subscribe to see more

Sources

3

10

0

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.